Table 2 Effectiveness and Utility Inputsa
Treatment | Hyponatremia Incidence (%) | Renal Impairment Incidence (%) | HE Incidence (%) | Hospital Length of Stay (Days) | Mortality (%) | Utility Values |
|---|---|---|---|---|---|---|
LVP after ascites | ||||||
Albumin | 8.8% [6] | 7.2% [5] | 3.1% [5] | – | 2.1% [5] | – |
Gelatin | 22.6% [6] | 10.1% [5] | 5.1% [5] | – | 6.1% [5] | – |
Saline | 14.3% [20] | 8.6% [20] | 5.4% [5]b | – | 2.9% [20] | – |
No fluid | 16.5% [6] | 11.3% [34] | 5.7% [34] | – | 3.8% [34] | – |
Decompensated cirrhosis | – | – | – | – | – | 0.74 |
Decompensated cirrhosis with encephalopathy | – | – | – | – | – | 0.55 |
SBP | ||||||
Antibiotics + albumin | – | 10% [7]e | – | 14 [7]e | 22% [7] | – |
Antibiotics alone | – | 33% [7]e | – | 13 [7]e | 41% [7] | – |
Spontaneous bacterial peritonitis | – | – | – | – | – | 0.45 |
HRS | ||||||
Albumin + terlipressin | – | 29.6% [8]c | – | – | 40.7% [8] | – |
Albumin + noradrenaline | – | 52.4% [23]c | – | – | 52.4% [23] | – |
Vasoconstrictor aloned | – | 75.0% [22]c | – | – | 87.5% [22]h | – |
Decompensated cirrhosis | – | – | – | – | – | 0.45 |